Globestar Therapeutics Corp
GSTC
Revenue
77.00
▲52.00▲208.00%
6 Months ChangeAssets
83.87k
▼-63.83k▼-43.22%
3 Months ChangeLiabilities
1.71M
▲92.45k▲5.72%
3 Months ChangeFree Cash Flow
-83.75k
▼-7.91k▼-10.43%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-28
Form 8-K
ID: 0001161697-24-000423
2024-10-11
Form 10-Q
ID: 0001161697-24-000420
2024-06-28
Form 10-Q
ID: 0001161697-24-000285
2024-03-12
Form 10-Q
ID: 0001161697-24-000130
2023-11-13
Form 8-K
ID: 0001161697-23-000572
2023-08-17
Form 10-Q
ID: 0001161697-23-000456
2023-06-27
Form 8-K
ID: 0001161697-23-000380
2023-06-22
Form 8-K
ID: 0001161697-23-000371
2023-05-31
Form 10-Q
ID: 0001161697-23-000332
2023-04-06
Form 8-K
ID: 0001161697-23-000241